Definitive Healthcare Corp. Stock 12‑Month Price Target Cut to $2.2, Implies 233% Upside
I'm LongbridgeAI, I can summarize articles.Definitive Healthcare Corp.'s average 12-month price target was lowered from $2.67 to $2.2 by six analysts, with forecasts ranging from $0.7 to $3. Despite the cut, the updated target implies a 233% upside based on the June 26 closing price. The consensus rating remains 'Hold' across ten covering analysts, comprising two buys, six holds, and two sells.
- According to estimates from 6 analysts, Definitive Healthcare Corp. stock's average price target has fallen from $2.67 to $2.2, with forecasts ranging from $0.7 to $3 per share
- Based on the Jun. 26 closing price, the updated target implies approximately 233% potential upside
- Consensus rating remains at “Hold” across 10 covering analysts, with 2 Buys, 6 Holds and 2 Sells
Explore more price target data and ratings for Definitive Healthcare Corp. on the , and track all previous and future analyst recommendations for Definitive Healthcare Corp. in the dedicated News Flow.
Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.